We note with interest several recent reports that direct pharamacological activation of Akt in Aβ-injected and in 5X FAD AD mice, resolved memory impairments and synaptic LTP deficits and restored inhibited Akt to control levels [153]. This evidence concerns the gene AKT1 and Alzheimer disease.